Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fertilization in Vitro | 17 | 2024 | 1292 | 1.390 |
Why?
|
Aneuploidy | 9 | 2023 | 551 | 1.340 |
Why?
|
Pregnancy-Associated Plasma Protein-A | 2 | 2018 | 60 | 1.150 |
Why?
|
Oocyte Donation | 2 | 2024 | 52 | 1.150 |
Why?
|
Reproductive Techniques, Assisted | 11 | 2024 | 497 | 1.100 |
Why?
|
Abortion, Spontaneous | 6 | 2023 | 530 | 1.000 |
Why?
|
Infertility | 6 | 2024 | 655 | 1.000 |
Why?
|
Blastocyst | 7 | 2023 | 433 | 0.980 |
Why?
|
Live Birth | 12 | 2024 | 512 | 0.910 |
Why?
|
Preimplantation Diagnosis | 5 | 2023 | 143 | 0.870 |
Why?
|
Embryo Implantation | 4 | 2023 | 270 | 0.820 |
Why?
|
Nuchal Translucency Measurement | 3 | 2019 | 59 | 0.720 |
Why?
|
Pregnancy Rate | 14 | 2023 | 649 | 0.700 |
Why?
|
Premature Birth | 5 | 2023 | 1771 | 0.660 |
Why?
|
Embryo Transfer | 9 | 2022 | 522 | 0.660 |
Why?
|
Chromosome Disorders | 2 | 2023 | 499 | 0.610 |
Why?
|
Down Syndrome | 3 | 2023 | 892 | 0.590 |
Why?
|
Prenatal Diagnosis | 4 | 2023 | 1264 | 0.560 |
Why?
|
Birth Rate | 6 | 2023 | 168 | 0.550 |
Why?
|
Pregnancy Outcome | 10 | 2024 | 2907 | 0.530 |
Why?
|
Chorionic Gonadotropin | 2 | 2023 | 457 | 0.510 |
Why?
|
Tissue Donors | 2 | 2024 | 2311 | 0.510 |
Why?
|
Oocytes | 5 | 2023 | 1165 | 0.490 |
Why?
|
Ontario | 9 | 2023 | 397 | 0.460 |
Why?
|
Pre-Eclampsia | 1 | 2023 | 1227 | 0.460 |
Why?
|
Pregnancy | 36 | 2024 | 29742 | 0.450 |
Why?
|
Sperm Injections, Intracytoplasmic | 3 | 2023 | 156 | 0.450 |
Why?
|
Diabetes, Gestational | 1 | 2023 | 1241 | 0.450 |
Why?
|
Genetic Testing | 5 | 2022 | 3530 | 0.450 |
Why?
|
Uterine Diseases | 2 | 2024 | 117 | 0.420 |
Why?
|
Semen | 4 | 2023 | 346 | 0.420 |
Why?
|
Cryopreservation | 3 | 2023 | 717 | 0.420 |
Why?
|
Maternal Age | 4 | 2019 | 807 | 0.310 |
Why?
|
Progesterone | 2 | 2023 | 742 | 0.310 |
Why?
|
Pregnancy Complications | 5 | 2022 | 2942 | 0.280 |
Why?
|
Hysteroscopy | 2 | 2024 | 67 | 0.280 |
Why?
|
Oocyte Retrieval | 3 | 2022 | 158 | 0.280 |
Why?
|
Fertility | 2 | 2022 | 773 | 0.240 |
Why?
|
Gynatresia | 1 | 2024 | 11 | 0.230 |
Why?
|
Retrospective Studies | 27 | 2024 | 80168 | 0.220 |
Why?
|
Cumulus Cells | 1 | 2023 | 22 | 0.220 |
Why?
|
Pregnancy Trimester, First | 2 | 2018 | 908 | 0.220 |
Why?
|
Vitrification | 1 | 2023 | 51 | 0.210 |
Why?
|
Leuprolide | 1 | 2023 | 314 | 0.190 |
Why?
|
Ovulation Induction | 1 | 2023 | 277 | 0.190 |
Why?
|
Female | 44 | 2024 | 390323 | 0.190 |
Why?
|
Insurance | 1 | 2022 | 113 | 0.180 |
Why?
|
alpha-Fetoproteins | 2 | 2023 | 222 | 0.180 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2020 | 25 | 0.180 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2020 | 44 | 0.180 |
Why?
|
Embryo Culture Techniques | 1 | 2021 | 84 | 0.180 |
Why?
|
Germ Cells | 1 | 2024 | 635 | 0.180 |
Why?
|
Spermatozoa | 1 | 2024 | 631 | 0.170 |
Why?
|
Pregnancy Trimester, Second | 2 | 2023 | 732 | 0.170 |
Why?
|
Erectile Dysfunction | 1 | 2023 | 451 | 0.170 |
Why?
|
Nifedipine | 1 | 2019 | 221 | 0.160 |
Why?
|
Ovarian Follicle | 2 | 2022 | 244 | 0.160 |
Why?
|
Informed Consent | 1 | 2024 | 1003 | 0.150 |
Why?
|
Endocrinology | 1 | 2024 | 441 | 0.150 |
Why?
|
Adult | 25 | 2024 | 219935 | 0.140 |
Why?
|
Estriol | 1 | 2016 | 51 | 0.140 |
Why?
|
State Government | 1 | 2019 | 381 | 0.140 |
Why?
|
Financing, Government | 1 | 2019 | 472 | 0.130 |
Why?
|
Eligibility Determination | 1 | 2019 | 419 | 0.130 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2020 | 376 | 0.130 |
Why?
|
Inhibins | 1 | 2016 | 209 | 0.130 |
Why?
|
Humans | 45 | 2024 | 758406 | 0.130 |
Why?
|
Insemination, Artificial, Heterologous | 1 | 2015 | 10 | 0.130 |
Why?
|
Infant, Newborn | 8 | 2023 | 26183 | 0.120 |
Why?
|
Birth Weight | 1 | 2023 | 2097 | 0.120 |
Why?
|
Azoospermia | 1 | 2015 | 28 | 0.120 |
Why?
|
Pregnancy, Multiple | 3 | 2023 | 215 | 0.120 |
Why?
|
Single Embryo Transfer | 1 | 2014 | 29 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1763 | 0.120 |
Why?
|
Cannabis | 1 | 2020 | 436 | 0.110 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2019 | 517 | 0.110 |
Why?
|
Labor, Induced | 1 | 2014 | 151 | 0.110 |
Why?
|
Tissue Adhesions | 2 | 2024 | 222 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15225 | 0.100 |
Why?
|
Obesity | 3 | 2023 | 12870 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2020 | 6520 | 0.090 |
Why?
|
Antihypertensive Agents | 1 | 2019 | 2016 | 0.090 |
Why?
|
Young Adult | 12 | 2024 | 58808 | 0.080 |
Why?
|
Cesarean Section | 2 | 2018 | 1385 | 0.080 |
Why?
|
Body Mass Index | 3 | 2023 | 12876 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2019 | 2215 | 0.080 |
Why?
|
Self Report | 1 | 2020 | 3714 | 0.080 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2023 | 3432 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2020 | 7818 | 0.080 |
Why?
|
Insurance, Health | 1 | 2020 | 2495 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5484 | 0.070 |
Why?
|
Canada | 3 | 2022 | 2111 | 0.070 |
Why?
|
Registries | 2 | 2022 | 8175 | 0.070 |
Why?
|
Cohort Studies | 4 | 2022 | 41256 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 3992 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 25956 | 0.060 |
Why?
|
Population Surveillance | 1 | 2015 | 2606 | 0.060 |
Why?
|
Coercion | 1 | 2024 | 69 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2020 | 4673 | 0.050 |
Why?
|
Chorionic Gonadotropin, beta Subunit, Human | 1 | 2023 | 81 | 0.050 |
Why?
|
Alkylating Agents | 1 | 2023 | 133 | 0.050 |
Why?
|
Insemination | 1 | 2022 | 18 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2020 | 5404 | 0.050 |
Why?
|
Sex Chromosome Aberrations | 1 | 2023 | 116 | 0.050 |
Why?
|
Follicular Phase | 1 | 2023 | 143 | 0.050 |
Why?
|
Donor Selection | 1 | 2024 | 227 | 0.050 |
Why?
|
Sperm Motility | 1 | 2023 | 265 | 0.050 |
Why?
|
Adolescent | 8 | 2024 | 87892 | 0.050 |
Why?
|
Cytogenetic Analysis | 1 | 2023 | 270 | 0.050 |
Why?
|
Oogenesis | 1 | 2022 | 124 | 0.050 |
Why?
|
Insemination, Artificial | 1 | 2022 | 99 | 0.050 |
Why?
|
Uterine Hemorrhage | 1 | 2023 | 242 | 0.050 |
Why?
|
Breast Feeding | 1 | 2010 | 1355 | 0.050 |
Why?
|
Trisomy | 1 | 2023 | 260 | 0.050 |
Why?
|
Middle Aged | 7 | 2024 | 219568 | 0.050 |
Why?
|
Educational Status | 2 | 2024 | 2513 | 0.050 |
Why?
|
Ploidies | 1 | 2021 | 275 | 0.050 |
Why?
|
Male | 6 | 2024 | 358747 | 0.050 |
Why?
|
Endometrium | 1 | 2022 | 403 | 0.040 |
Why?
|
Sperm Count | 1 | 2020 | 228 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2023 | 1339 | 0.040 |
Why?
|
Culture Media | 1 | 2021 | 899 | 0.040 |
Why?
|
Family Planning Services | 1 | 2022 | 265 | 0.040 |
Why?
|
Infant | 4 | 2023 | 36055 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2023 | 859 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20055 | 0.040 |
Why?
|
Infertility, Female | 1 | 2024 | 759 | 0.040 |
Why?
|
Prolactin | 1 | 2020 | 621 | 0.040 |
Why?
|
Apgar Score | 1 | 2018 | 126 | 0.040 |
Why?
|
Semen Analysis | 1 | 2020 | 234 | 0.040 |
Why?
|
Luteinizing Hormone | 1 | 2020 | 820 | 0.040 |
Why?
|
Cannabinoids | 1 | 2020 | 172 | 0.040 |
Why?
|
Pregnant Women | 1 | 2022 | 562 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2022 | 64378 | 0.030 |
Why?
|
Fetal Death | 1 | 2018 | 434 | 0.030 |
Why?
|
Gonadal Steroid Hormones | 1 | 2020 | 701 | 0.030 |
Why?
|
Down-Regulation | 1 | 2023 | 2904 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 958 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8499 | 0.030 |
Why?
|
Ovarian Function Tests | 1 | 2015 | 11 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1673 | 0.030 |
Why?
|
Estradiol | 1 | 2022 | 1933 | 0.030 |
Why?
|
Counseling | 1 | 2022 | 1541 | 0.030 |
Why?
|
Prenatal Care | 1 | 2022 | 1129 | 0.030 |
Why?
|
Cardiotocography | 1 | 2014 | 24 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22032 | 0.030 |
Why?
|
Postpartum Hemorrhage | 1 | 2018 | 265 | 0.030 |
Why?
|
Fetal Growth Retardation | 1 | 2018 | 579 | 0.030 |
Why?
|
Fetus | 1 | 2021 | 1859 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21017 | 0.030 |
Why?
|
Infant, Premature | 1 | 2023 | 2092 | 0.030 |
Why?
|
Program Evaluation | 1 | 2021 | 2492 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3527 | 0.030 |
Why?
|
Urban Population | 1 | 2020 | 2025 | 0.030 |
Why?
|
Gestational Age | 1 | 2021 | 3565 | 0.030 |
Why?
|
Antidepressive Agents | 1 | 2023 | 2889 | 0.020 |
Why?
|
Biopsy | 1 | 2022 | 6768 | 0.020 |
Why?
|
Child | 3 | 2023 | 79818 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2821 | 0.020 |
Why?
|
Home Childbirth | 1 | 2010 | 55 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18358 | 0.020 |
Why?
|
Testosterone | 1 | 2020 | 2471 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2411 | 0.020 |
Why?
|
United States | 3 | 2022 | 72136 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15651 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4539 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54137 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9599 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22029 | 0.020 |
Why?
|
Risk Factors | 3 | 2020 | 73809 | 0.020 |
Why?
|
Depression | 1 | 2023 | 8057 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10652 | 0.010 |
Why?
|
Ultrasonography | 1 | 2015 | 5952 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2019 | 15785 | 0.010 |
Why?
|
Animals | 2 | 2023 | 167768 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 42062 | 0.010 |
Why?
|
Mothers | 1 | 2010 | 2189 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23884 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 21272 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13276 | 0.010 |
Why?
|
Smoking | 1 | 2010 | 9051 | 0.010 |
Why?
|
Time Factors | 1 | 2010 | 39872 | 0.000 |
Why?
|
Concepts
(182)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_